About Persevere Therapeutics
Persevere Therapeutics is a private company based in Chesterbrook, Pennsylvania, incorporated in 2025 in Delaware. It has reported $1,574,999 raised in one offering on Form D since March 2026. Its chief executive is Greg Bosch.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Mar 4, 2026 | $1,574,999of $4.9M target | 12 | $131K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Persevere Therapeutics's Form D filed Mar 4, 2026.
